Novel Benzimidazole Derivatives As Ep4 Antagonists

Abstract

The present invention relates to novel benzimidazole derivatives of the general formula (I), processes for their preparation and their use for the production of pharmaceutical compositions for the treatment of diseases and indications that are connected with the receptor EP4.


Claims

Download Citation


Sign in to the Lens

Feedback